HealthDay - MONDAY, June 23 (HealthDay News) -- U.S. researchers boosted the level
of early-stage ovarian cancer tracking down by 20 percent through use of a
blood test to detect a tumor marker as well as a woman's report of
new-onset symptoms.

More: - Read More